Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Scott Adams

Physician Assistant Olympia, WA Physician Assistant

NPI 1558642066 CMS profile 10748578

3909 9Th Ave Sw, Olympia, WA 98502

Open in the dashboard

General payments

$1,390

63 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Scott Adams of Olympia, WA is reported in the CMS Open Payments database as having received $1,390 across 63 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 74th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $502 20
2024 General $330 15
2023 General $142 7
2022 General $235 14
2021 General $181 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Scott Adams
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Scott Adams were reported at $502. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Scott Adams Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $181 $132 $37–$438 $132
2022 $235 $155 $48–$522 $149
2023 $142 $167 $52–$557 $160
2024 $330 $178 $55–$600 $164
2025 $502 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Nevro Corp. $829 41 payments
  2. Boston Scientific Corporation $349 11 payments
  3. Globus Medical, Inc. $141 8 payments
  4. SPR Therapeutics, Inc $39 1 payment
  5. Nalu Medical, Inc. $32 2 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $1,390 63 payments
Products named General payments · program years 2021–2025
  1. Omnia $416 21 payments
  2. Senza Spinal Cord Stimulator $413 20 payments
  3. Intracept $291 9 payments
  4. Senza Spinal Cord Stimulator $141 8 payments
  5. SPRINT PNS System $39 1 payment
  6. Nalu Neurostimulation System $32 2 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 31 drugs

Part D claims

4,631

Median for Physician Assistant: 241

Drug cost

$110,432

Median for Physician Assistant: $4,110

Branded share of claims

32.5%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 858 $16,690
Oxycodone Hcl Generic 896 $14,315
Buprenorphine Generic 84 $14,019
Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl Brand 76 $11,571
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 346 $8,728
Lidocaine Generic 53 $6,614
Oxycontin Oxycodone Hcl Brand 11 $5,430
Gabapentin Generic 267 $4,638
Pregabalin Generic 185 $4,167
Tramadol Hcl Generic 441 $3,018

The 10 drugs with the highest cost, of 31 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 44 billing codes

Paid by Medicare

$148,281

Of which drugs: $3,097

Medicare patients

1,047

Average age 75

Services billed

11,572

639 women, 408 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 31%
Depression 30%
Ischemic heart disease 25%
Chronic kidney disease 21%
Atrial fibrillation 20%
Heart failure 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 92 8,445 $834
Injection, methylprednisolone acetate, 80 mg J1040 Office 41 42 $276

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

63 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Washington

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record